Waters
WAT
435.99
-0.44
-0.10%
Waters
US · WAT
#515 by market cap
Listed 1970
435.99
-0.44
-0.10%
Live - 5344 symbols - heartbeat 124s ago
· 2026-10-07 20:02
After-hours
426.80
-2.11%
- Market cap
- 42.84B
- P/E (TTM)i
- 110.38
- P/Bi
- 2.82
- EPSi
- 10.76
- Div yieldi
- 0.00%
- 52W posi
- 89%
Reader sentiment
Are you bullish or bearish on WAT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.1 percentage points.
Institutional ownership
- Held by institutions
- 101.60% -1.14pp
- Institutions
- 1,403 -7
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund86.08%
Hedge Fund8.52%
Public Company3.00%
Government Pension Fund1.49%
Private Company1.27%
VC/PE Fund0.29%
Insurance Company0.26%
Sovereign Wealth Fund0.25%
Family Office/Trust0.18%
Top holders
BlackRock
8.64%
Vanguard Capital Management, LLC
7.09%
T. Rowe Price Group, Inc.
6.10%
Vanguard Portfolio Management, LLC
4.83%
MFS Investment Management
4.71%
State Street Global Advisors
4.46%
AllianceBernstein
2.74%
Geode Capital Management, LLC
2.68%
Invesco Ltd.
2.53%
Fundsmith, LLP
2.31%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 11 sells
| Name | Role | Stake |
|---|---|---|
| Udit Batra | Chief Executive Officer | 0.03% |
| Christopher Kuebler | Independent Director | 0.02% |
| Amol Chaubal | Senior Vice President | 0.01% |
| Flemming Ornskov | Independent Chairperson | 0.01% |
| Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | 0.01% |
| Mark Vergnano | Independent Director | 0.00% |
| Wei Jiang | Independent Director | 0.00% |
| Richard Fearon | Independent Director | 0.00% |
| Linda Baddour | Independent Director | 0.00% |
| Pearl Huang | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Wei Jiang | Independent Director | Other Acquisition | +57 | -- |
| 2026-09-29 | Heather Knight | Director | Other Acquisition | +57 | -- |
| 2026-08-05 | Christopher Kuebler | Independent Director | Derivative Exercise and Sale | -3,626 | $136.43–397.94 |
| 2026-06-29 | Wei Jiang | Independent Director | Other Acquisition | +67 | -- |
| 2026-06-29 | Heather Knight | Director | Other Acquisition | +63 | -- |
| 2026-06-23 | Robert Carpio | Senior Vice President of Waters Division | Sale to Issuer | -189 | $369.18 |
| 2026-05-11 | Amol Chaubal | Senior Vice President | Sale to Issuer | -239 | $352.21 |
| 2026-04-05 | Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | Sale to Issuer | -302 | $304.09 |
| 2026-03-30 | Wei Jiang | Independent Director | Other Acquisition | +64 | -- |
| 2026-03-30 | Heather Knight | Director | Other Acquisition | +68 | -- |
| 2026-03-15 | Wei Jiang | Independent Director | Open Market Acquisition | +500 | $289.46 |
| 2026-03-05 | Richard Fearon | Independent Director | Open Market Acquisition | +1,000 | $306.34 |
| 2026-03-01 | Udit Batra | Chief Executive Officer | Sale to Issuer | -3,417 | $307.23 |
| 2026-03-01 | Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | Sale to Issuer | -410 | $307.23 |
| 2026-03-01 | Amol Chaubal | Senior Vice President | Sale to Issuer | -709 | $307.23 |
| 2026-02-24 | Linda Baddour | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Linda Baddour | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
| 2026-02-24 | Richard Fearon | Independent Director | Other Acquisition | +23 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 20:02:24 · For reference only, not investment advice and not tailored to your situation.